Product Description: The treatment of painful syndromes of muscle remains incompletely understood and controversial. While the use of botulinum toxin type A (BTX-A) in the treatment of conditions associated with involuntary muscle contraction, such as focal dystonia and spasticity, is supported by prospective, randomized clinical research, comparable research in pain syndromes remains to be fully explored...read more